Daniel G Kaye

CIK 1556974 · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.50M

Companies

6

Total Filings

41

Lifetime Open-Market Net

$41.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AB Director 48,527 $36.44 $1.77M -$196.9K 12 2026-05-22
EQHpC Director 60,086 $16.20 $973.1K -$475.2K 8 2026-05-21
CME Director 4,200 $269.53 $1.13M -$141.2K 9 2025-06-26
EQHpA Director 41,514 $19.56 $812.0K $176.9K 3 2020-05-21
EQH Director 18,474 $44.02 $813.2K $120.0K 3 2019-05-28
FERRELLGAS PARTNERS L P (FGP) Delisted Director 25,000 $557.7K 6 2015-10-06

Recent Filings · Page 3 of 5

41 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-29 CME Grant (A) +551 $120.2K EDGAR
2021-05-24 AB Grant (A) +3,918 $170.0K EDGAR
2021-05-21 EQHpC Grant (A) +4,845 $0 EDGAR
2020-06-29 CME Grant (A) +712 $0 EDGAR
2020-05-21 EQHpA Grant (A) +9,040 $0 EDGAR
2020-05-21 AB Grant (A) +7,176 $170.0K EDGAR
2020-03-19 EQHpA Buy (P) +8,000 $87.5K EDGAR
2020-03-12 EQHpA Buy (P) +6,000 $89.4K EDGAR
2019-06-27 CME Grant (A) +606 $0 EDGAR
2019-05-28 EQH Grant (A) +7,630 $0 EDGAR
Showing 2130 of 41
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.